Lazard Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7K | Sell |
|
|||||
2025
Q1 | $304K | Buy |
|
|||||
2024
Q4 | $265K | Sell |
|
|||||
2024
Q3 | $283K | Sell |
|
|||||
2024
Q2 | $446K | Buy |
|
|||||
2024
Q1 | $328K | Buy |
|
|||||
2023
Q4 | $229K | Buy |
|
|||||
2023
Q3 | $280K | Buy |
|
|||||
2023
Q2 | $128K | Buy |
|
|||||
2023
Q1 | $93K | Buy |
|
|||||
2022
Q4 | $79K | Sell |
|
|||||
2022
Q3 | $188K | Buy |
|
|||||
2022
Q2 | $79K | Buy |
|
|||||
2022
Q1 | $79K | Sell |
|
|||||
2021
Q4 | $129K | Sell |
|
|||||
2021
Q3 | $162K | Sell |
|
|||||
2021
Q2 | $150K | Sell |
|
|||||
2021
Q1 | $485K | Sell |
|
|||||
2020
Q4 | $5.06M | Buy |
|
|||||
2020
Q3 | $55K | Sell |
|
|||||
2020
Q2 | $88K | Sell |
|
|||||
2020
Q1 | $108K | Buy |
|
|||||
2019
Q4 | $3K | Sell |
|
|||||
2019
Q3 | $13K | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $109K | Hold |
|
|||||
2018
Q3 | $161K | Sell |
|
|||||
2018
Q2 | $973K | Buy |
|